07 Jan 2001

Phosphalugel® (Phosphalugel® Suspension) - Deutschland

Updated: 07 Jan 2001


Gastritis, Reizmagen, Hyperazidität, Schwangerschafts-Sodbrennen, Magenbeschwerden nach Alkohol- und Nikotinmißbrauch sowie nach Diätfehlern.

Phosphalugel® Description, Presentation and Dosage

Phosphalugel® Description

Phosphalugel® Drug Class Description


Phosphalugel® Drug Description

100 g enth.: Aluminiumphosphat H2O-frei 13 g.

Phosphalugel® Generic Name

Phosphalugel® Suspension

Phosphalugel® Presentation

Phosphalugel® Presentation


Phosphalugel® Manufacturer


Related Learning Zones

IL-17A in Psoriasis

IL-17A in Psoriasis

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Phosphalugel® Dosage

Phosphalugel® Adult Dosage

Sorbitol, Agar, Pektin (E 440), Calciumsulfat, Kaliumsorbat, künstliches Orangenaroma, Wasser.

Phosphalugel® Elderly Dosage

1 Btl. entspr. 0,26 BE.

Phosphalugel® Precautions, Reactions and Contraindications

Phosphalugel® Special Precautions

Phosphalugel® Adverse Reactions

Phosphalugel® Adverse Reactions

A 43

Related Drugs - Gastroenterology

Back to top